Verition Fund Management
ISEE

Verition Fund Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Verition Fund Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-50,000
Closed -$1.97M – 2828
2023
Q2 		$1.97M Buy
+50,000
New +$1.76M 0.03% 679

Verition Fund Management's ISEE Position: Q3 2023 in Review

Verition Fund Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 225,146 shares — an estimated $8.86M sold.

Verition Fund Management first reported a position in ISEE in Q2 2020 and held it in 4 quarters. The position peaked at $8.86M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Verition Fund Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Verition Fund Management sold 225,146 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $8.86M.
  • Verition Fund Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Verition Fund Management's IVERIC bio, Inc. Common Stock position peaked at $8.86M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Verition Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.